Pfizer concludes phase 3 study of COVID-19 vaccine candidate, says it's 95% effective

 New York, Nov 18: Global drugmakers Pfizer and BioNTech said on Wednesday their COVID-19 vaccine candidate is 95 per cent effective, including in adults over 65 years of age, a major announcement coming just two days after Moderna said its virus

from World News, International Breaking News, Latest World news headlines - Oneindia International News https://ift.tt/3nAh7aX
https://ift.tt/eA8V8J